THY1 and hepatocellular carcinoma: HBx and transforming growth factor beta 1 (TGF-β1) contribute to the malignant transformation of HPCs into hepatic CSCs, and correlate with the stem cell markers EpCAM and CD90 and the poor survival of HCC patients.